Display options
Cite
Nielsen JD, Stoltenberg M, Siemsen M, et al. Anvendelse af fibrinolytika ved behandling af akut myokardieinfarkt i Danmark. En spørgeskemaundersøgelse. [Use of fibrinolytics in the treatment of acute myocardial infarction in Denmark. A questionnaire study]. Ugeskr Laeger. 1990;152(33):2368-70
Nielsen, J. D., Stoltenberg, M., Siemsen, M., Juul, A., Pedersen, F., & Madsen, J. K. (1990). Anvendelse af fibrinolytika ved behandling af akut myokardieinfarkt i Danmark. En spørgeskemaundersøgelse. [Use of fibrinolytics in the treatment of acute myocardial infarction in Denmark. A questionnaire study]. Ugeskrift for laeger, 152(33), 2368-70.
Nielsen, J D, et al. "Anvendelse af fibrinolytika ved behandling af akut myokardieinfarkt i Danmark. En spørgeskemaundersøgelse." [Use of fibrinolytics in the treatment of acute myocardial infarction in Denmark. A questionnaire study]. Ugeskrift for laeger vol. 152,33 (1990): 2368-70.
Nielsen JD, Stoltenberg M, Siemsen M, Juul A, Pedersen F, Madsen JK. Anvendelse af fibrinolytika ved behandling af akut myokardieinfarkt i Danmark. En spørgeskemaundersøgelse. [Use of fibrinolytics in the treatment of acute myocardial infarction in Denmark. A questionnaire study]. Ugeskr Laeger. 1990 Aug 13;152(33):2368-70. Danish. PMID: 2120830.
Copy Download .nbib Format: NLM
Share it on

Ugeskr Laeger. 1990 Aug 13;152(33):2368-70.

[Use of fibrinolytics in the treatment of acute myocardial infarction in Denmark. A questionnaire study].

Ugeskrift for laeger

[Article in Danish]
J D Nielsen, M Stoltenberg, M Siemsen, A Juul, F Pedersen, J K Madsen

Affiliations

  1. Bispebjerg Hospital, København, hjertemedicinsk afdeling Y.

PMID: 2120830

Abstract

Questionnaires were sent to all Danish departments admitting patients with acute myocardial infarction (AMI) in order to investigate the attitudes of the departments to thrombolytic therapy in AMI. Two questionnaires were used: one with few questions which was answered by all 68 departments, and a more comprehensive questionnaire which was answered by 51 departments. The study shows that thrombolytic therapy now is use in all departments as opposed to 25% two years ago. In connection with introduction of thrombolytic therapy scientific studies are performed in 75% of the departments. In all departments, streptokinase (SK) is the drug of first choice and recombinant tissue plasminogen activator (rt-PA) is used in 2/3 of the departments in cases where SK-antibodies are suspected.

Similar articles

[No authors listed]
Oper Dent. 2017 May/Jun;42(3):342-343. doi: 10.2341/1559-2863-42.3.342.
PMID: 28467255

[No authors listed]
PM R. 2021 Dec;13(12):E1-E12. doi: 10.1002/pmrj.12749.
PMID: 34931485

[No authors listed]
PM R. 2021 Aug;13(8):E1-E8. doi: 10.1002/pmrj.12676.
PMID: 34351061

Substances

MeSH terms

Publication Types

LinkOut - more resources